Search
for

    Sort by

    Research 181–210 of 1000+

    1. Prostate cancer and androgenic alopecia Expert Review of Endocrinology & Metabolism · 2012
    2. Hair loss at 20 associated with prostate cancer risk later in life Cancer · 2011
    3. 411 THE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS AS PROGNOSTIC BIOMARKERS IN PROSTATE CANCER European Urology Supplements · 2011
    4. 410 NON-INVASIVE DIAGNOSIS OF PROSTATE CANCER FROM BODY FLUIDS USING A PANEL OF TUMOR SUPPRESSOR GENES European Urology Supplements · 2011
    5. Total prostate volume as risk factor for semen pathologies in ageing male Journal of Men's Health · 2010
    6. S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION? European Urology Supplements · 2010
    7. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    8. 1408 INDUCTION OF SECRETED WNT FACTOR WISP1/CCN4 BY HUMAN PROSTATE STROMAL CELLS BY MICROENVIORNMENTAL HYPOXIA The Journal of Urology · 2010
    9. 1406 DETECTION OF MEMBRANE ANDROGEN-BINDING SITE IN LIVING RAT PROSTATE AND EVALUATION OF ITS ROLE IN PROSTATE BLOOD FLOW REGULATION The Journal of Urology · 2010
    10. S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8) European Urology Supplements · 2009
    11. Urological Oncology: Prostate Cancer The Journal of Urology · 2008
    12. Prostate cancer update: 2007 Current Opinion in Internal Medicine · 2008
    13. Faculty Opinions recommendation of Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2007
    14. Efectos de la terapia combinada del D-004 y el Finasteride sobre la hiperplasia de próstata inducida por testosterona en ratas El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · 2007
    15. Body Mass Index is Associated with Increased Risk of aggressive and Decreased Risk of Non-aggressive Prostate Cancer American Journal of Epidemiology · 2006
    16. Prostate Specific Antigen Levels in Diabetic and Non-Diabetic Men from the 2001–2002 National Health and Nutrition Examination Survey American Journal of Epidemiology · 2006
    17. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. The Journal of Urology · 2005
    18. Genetic analysis of the role of androgen metabolism in the pathogenesis of prostate cancer SUNScholar (Stellenbosch University) · 2004
    19. IMPLICAÇÕES DA TOMA CRÓNICA DA FINASTERIDE PARA A ALOPÉCIA ANDROGENÉTICA NO CARCINOMA DA PRÓSTATA Zenodo (CERN European Organization for Nuclear Research) · 2023
    20. Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent HAMDAN MEDICAL JOURNAL · 2021
    21. Role of serum androgens and prostate-specific antigen levels in males with androgenetic alopecia Human Andrology · 2019
    22. Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia Journal of The American Academy of Dermatology · 2019
    23. P152 : Association between degrees of alopecia and prostate specific antigen level in men with androgenetic alopecia 프로그램북(구 초록집) · 2018
    24. Faculty Opinions recommendation of Androgenetic alopecia and risk of prostate cancer: a systematic review and meta-analysis. 2013
    25. 341 ANDROGENETIC ALOPECIA AT VARIOUS AGES AND PROSTATE CANCER RISK IN AN EQUAL ACCESS MULTIETHNIC CASE CONTROL SERIES OF VETERANS The Journal of Urology · 2012
    26. 409 ANDROGEN RECEPTOR GENE POLYMORPHISM (SNP RS6152) – ITS RELATIONSHIP TO ANDROGEN-SENSITIVE GENES EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA, CARCINOMA OF THE PROSTATE AND ANDROGENETIC ALOPECIA European Urology Supplements · 2011
    27. 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY The Journal of Urology · 2010
    28. 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia The Year book of endocrinology · 2008
    29. Patients with a large prostate show a higher prevalence of androgenetic alopecia Archives of Dermatological Research · 2005
    30. The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia Cancer Epidemiology, Biomarkers & Prevention · 2005 · 76 citations